Publication | Closed Access
Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy
16
Citations
24
References
2008
Year
Breast OncologyMedicineImmunologyClinical TrialsPathologyBreast CancerPlasma EndoglinHormone TherapyCancer TreatmentEndocrinologyOncologyEndocrine-related Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1